Morgan Stanley’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$39.8K Buy
8,693
+1,482
+21% +$6.79K ﹤0.01% 6429
2025
Q1
$35.2K Sell
7,211
-13,398
-65% -$65.4K ﹤0.01% 6381
2024
Q4
$138K Sell
20,609
-1,594
-7% -$10.7K ﹤0.01% 5927
2024
Q3
$172K Buy
22,203
+21,490
+3,014% +$166K ﹤0.01% 5805
2024
Q2
$4.28K Sell
713
-9,402
-93% -$56.4K ﹤0.01% 6885
2024
Q1
$91.2K Sell
10,115
-41,742
-80% -$376K ﹤0.01% 6030
2023
Q4
$491K Buy
51,857
+38,374
+285% +$364K ﹤0.01% 5620
2023
Q3
$160K Sell
13,483
-35,650
-73% -$424K ﹤0.01% 5685
2023
Q2
$1.2M Buy
49,133
+30,447
+163% +$746K ﹤0.01% 4726
2023
Q1
$585K Buy
18,686
+2,320
+14% +$72.6K ﹤0.01% 5162
2022
Q4
$1.15M Buy
16,366
+2,365
+17% +$166K ﹤0.01% 4793
2022
Q3
$1.21M Sell
14,001
-1,907
-12% -$164K ﹤0.01% 4772
2022
Q2
$1.32M Sell
15,908
-37,610
-70% -$3.11M ﹤0.01% 4834
2022
Q1
$8.9M Sell
53,518
-90,751
-63% -$15.1M ﹤0.01% 3042
2021
Q4
$24.1M Buy
144,269
+22,593
+19% +$3.78M ﹤0.01% 1974
2021
Q3
$10.5M Sell
121,676
-36,379
-23% -$3.14M ﹤0.01% 2831
2021
Q2
$8.58M Buy
158,055
+156,770
+12,200% +$8.51M ﹤0.01% 3164
2021
Q1
$76K Sell
1,285
-2,114
-62% -$125K ﹤0.01% 6151
2020
Q4
$177K Buy
3,399
+2,176
+178% +$113K ﹤0.01% 5651
2020
Q3
$59K Sell
1,223
-1,113
-48% -$53.7K ﹤0.01% 5665
2020
Q2
$122K Buy
2,336
+2,036
+679% +$106K ﹤0.01% 5308
2020
Q1
$13K Sell
300
-2,678
-90% -$116K ﹤0.01% 5956
2019
Q4
$120K Buy
2,978
+2,328
+358% +$93.8K ﹤0.01% 5590
2019
Q3
$21K Sell
650
-6,848
-91% -$221K ﹤0.01% 5992
2019
Q2
$578K Buy
7,498
+6,765
+923% +$521K ﹤0.01% 4528
2019
Q1
$130K Sell
733
-1,113
-60% -$197K ﹤0.01% 5272
2018
Q4
$436K Buy
1,846
+711
+63% +$168K ﹤0.01% 4868
2018
Q3
$243K Buy
+1,135
New +$243K ﹤0.01% 5360